These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28330652)

  • 1. Shedding Light on Cardiac Allograft Vasculopathy: OCT to Predict Progression of Disease.
    Baran DA
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):785-786. PubMed ID: 28330652
    [No Abstract]   [Full Text] [Related]  

  • 2. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography for the evaluation of asymmetric cardiac allograft vasculopathy in a child.
    Greenway SC; Hosking M; Harris KC
    Pediatr Transplant; 2014 Sep; 18(6):E190-2. PubMed ID: 24953969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study).
    Khandhar SJ; Yamamoto H; Teuteberg JJ; Shullo MA; Bezerra HG; Costa MA; Selzer F; Lee JS; Marroquin OC; McNamara DM; Mulukutla SR; Toma C
    J Heart Lung Transplant; 2013 Jun; 32(6):596-602. PubMed ID: 23499356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intimal lesions detected by optical coherence tomography herald intraluminal progression of cardiac allograft vasculopathy associated with humoral rejection.
    Regamey J; Adjedj J; Rotman S; Hullin R
    Eur Heart J; 2019 Jun; 40(21):1739. PubMed ID: 30753431
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of optical coherence tomography in pediatric heart transplant patients.
    Ulrich SM; Lehner A; Birnbaum J; Heckel S; Haas NA; Hakami L; Schramm R; Dalla Pozza R; Fischer M; Kozlik-Feldmann R
    Int J Cardiol; 2017 Feb; 228():205-208. PubMed ID: 27866017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Nature of Nodular Calcification in Cardiac Allograft Vasculopathy.
    Kiyose Y; Shiraki T; Mizote I; Nakamura D; Tsukamoto Y; Yokoi K; Kioka H; Ohtani T; Hikoso S; Minami S; Sakata Y
    JACC Cardiovasc Interv; 2021 Jun; 14(12):1378-1380. PubMed ID: 34052153
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography.
    Shan P; Dong L; Maehara A; Nazif TM; Ali ZA; Rabbani LE; Apfelbaum MA; Dalton K; Marboe CC; Mancini DM; Mintz GS; Weisz G
    Am J Cardiol; 2016 Apr; 117(8):1361-8. PubMed ID: 26920081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Intracoronary Imaging Assessment of Cardiac Allograft Vasculopathy With Histopathologic Confirmation.
    Yokoi K; Otsuka F; Mizote I; Shiraki T; Tsukamoto Y; Nakamura D; Ohtani T; Hikoso S; Ikeda Y; Hatakeyama K; Sakata Y
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2305-2307. PubMed ID: 32861631
    [No Abstract]   [Full Text] [Related]  

  • 13. Current diagnostic and treatment strategies for cardiac allograft vasculopathy.
    Chang DH; Kobashigawa JA
    Expert Rev Cardiovasc Ther; 2015 Oct; 13(10):1147-54. PubMed ID: 26401922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of cardiac allograft vasculopathy detected by optical coherence tomography.
    Yamada R; Yoshida K; Okura H
    Coron Artery Dis; 2015 Aug; 26(5):459-60. PubMed ID: 25714071
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation.
    Mirelis JG; García-Pavía P; Cavero MA; González-López E; Echavarria-Pinto M; Pastrana M; Segovia J; Oteo JF; Alonso-Pulpón L; Escaned J
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):571-8. PubMed ID: 25522835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies.
    Aoki T; Rodriguez-Porcel M; Matsuo Y; Cassar A; Kwon TG; Franchi F; Gulati R; Kushwaha SS; Lennon RJ; Lerman LO; Ritman EL; Lerman A
    Atherosclerosis; 2015 Mar; 239(1):203-8. PubMed ID: 25618027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the development of cardiac allograft vasculopathy.
    Seki A; Fishbein MC
    Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy.
    Guddeti RR; Matsuo Y; Matsuzawa Y; Aoki T; Lerman LO; Kushwaha SS; Lerman A
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.